A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT06996782 · RECRUITING

Trial details

NCT number: NCT06996782
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Non-small Cell Lung Cancer

Start date: 2025-11-24
Primary completion: 2029-02-23
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.